The role of primary chemotherapy for prostate cancer: has the time come?

Current Urology Reports
P Paula Hruska, Joel Picus

Abstract

Current treatments for patients with prostate cancer generally are successful. However, a subset of patients identified with high-risk prostate cancer likely will recur after local therapy. The optimal treatment plan for these patients has not been determined. The search for an effective treatment for this subset of prostate cancer patients has focused on multi-modality therapy. Although chemotherapy has proven clinical and survival benefits for patients with metastatic disease, its role in earlier stages of the disease is being investigated. Current data have demonstrated that neoadjuvant or adjuvant chemotherapy is relatively safe and feasible. There also is emerging evidence of clinical benefit when early chemotherapy is combined with local treatments. Further investigation through prospective, randomized trials is critical to define the precise role of this modality in high-risk populations.

References

Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
May 30, 1998·Journal of the National Cancer Institute·M W KattanP T Scardino
Sep 28, 1998·JAMA : the Journal of the American Medical Association·P C AlbertsenM J Barry
May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W KantoffN J Vogelzang
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A PettawayC J Logothetis
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J ZelefskyS A Leibel
Nov 9, 2000·BJU International·J WangJ Waxman
Jan 17, 2002·The Journal of Urology·Gerald W HullPeter T Scardino
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markus GraefenMichael W Kattan
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomasz M BeerCelestia S Higano
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
May 13, 2005·The New England Journal of Medicine·Anna Bill-AxelsonUNKNOWN Scandinavian Prostate Cancer Group Study No. 4
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Phillip G FebboWilliam K Oh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medicina
Ramūne VisockieneElona Juozaityte
Surgical Oncology Clinics of North America
Courtney L ScaifeR Dirk Noyes
The Cancer Journal From Scientific American
E E Vokes, A M Mauer
© 2022 Meta ULC. All rights reserved